Systematic Literature Review and Network Meta-Analysis of Treatments for Relapsed/Refractory Multiple Myeloma Patients

被引：0
|
作者：
van Beurden-Tan, Chrissy H. Y. [1 ]
Franken, Margreet [2 ]
Blommestein, Hedwig [2 ]
Uyl-de Groot, Carin [2 ]
Sonneveld, Pieter [1 ]
机构：
[1] Erasmus MC, Canc Inst, Dept Hematol, Rotterdam, Netherlands
[2] Inst Hlth Policy & Management, Inst Med Technol Assessment, Rotterdam, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期
关键词：
D O I：
10.1016/j.clml.2017.03.260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS-258
引用
收藏
页码：E144 / E144
页数：1
相关论文
共 50 条
  • [41] Network Meta-Analysis of Randomized Trials in Relapsed/Refractory Multiple Myeloma: Relative Efficacy for Patients Who Are Lenalidomide-Refractory
    Kastritis, Efstathios
    Harvey, Rebecca
    Cranmer, Holly
    Bianco, Martina
    Fenu, Elisabetta
    La Porte, Charles
    Ramasamy, Karthik
    [J]. BLOOD, 2023, 142
  • [42] UPDATED RESULTS OF A SYSTEMATIC REVIEW OF THE RELATIVE EFFECTIVENESS OF TREATMENTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Maguire, A.
    Schmitz, S.
    Kuhn, I.
    Haller, E.
    Khan, A.
    Cook, G.
    O'Dwyer, M.
    Walsh, C.
    Ruggeri, K.
    [J]. HAEMATOLOGICA, 2016, 101 : 538 - 538
  • [43] Systematic Review and Network Meta-Analysis of Treatment Outcomes for Multiple Myeloma
    Armoiry, Xavier
    Tsertsvadze, Alexander
    Connock, Martin
    Melendez-Torres, G. J.
    Clarke, Aileen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (25) : 2975 - +
  • [44] Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis
    Luo, Xian-Wu
    Du, Xue-Qing
    Li, Jie-Li
    Liu, Xiao-Ping
    Meng, Xiang-Yu
    [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 2817 - 2823
  • [45] Efficacy and toxicity of histone deacetylase inhibitors in relapsed/refractory multiple myeloma: Systematic review and meta-analysis of clinical trials
    Gao, Xiao
    Shen, Lijing
    Li, Xiang
    Liu, Jiaying
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (02) : 1057 - 1068
  • [46] A Systematic Review and Network Meta-Analysis of Randomized Data on Efficacy of Novel Therapy Combinations in Patients with Lenalidomide Refractory Multiple Myeloma
    Mohyuddin, Ghulam Rehman
    Hampton, Jill
    Aziz, Muhammad
    Khuder, Sadik
    Malik, Saad Ullah
    McClune, Brian
    Abdallah, Al-Ola
    [J]. BLOOD, 2020, 136
  • [47] A systematic review and meta-analysis of randomized data on monoclonal antibodies added to proteasome inhibitor or immunomodulatory backbones in patients with relapsed and refractory multiple myeloma
    Kortuem, M.
    Schulat, C.
    Kerssenboom, R.
    Jakobs, J.
    Jensen, A.
    Mendes, J. A. D.
    Blees, A.
    Rasche, L.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 236 - 237
  • [48] Efficacy of Isatuximab Combination Regimens in Patients with Relapsed and Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
    Htut, Thura Win
    Phyu, Ei Moe
    Win, Myint Aung
    Thein, Kyaw Zin
    [J]. BLOOD, 2023, 142
  • [49] EFFICACY OF TREATMENTS IN CHILDREN WITH RELAPSED/REFRACTORY ACUTE LYMPHOCYTIC LEUKEMIA (R/R ALL): A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
    Martin, A. L.
    Thomas, S. K.
    Cota, M.
    Hao, Y.
    Zhang, Y.
    Turner, M.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A89 - A89
  • [50] Meta-analysis of the efficacy of treatments for newly diagnosed and relapsed/refractory multiple myeloma with del(17p)
    Liu, Jinghua
    Yang, Hui
    Liang, Xiaochan
    Wang, Yuxin
    Hou, Jian
    Liu, Yanqin
    Wang, Jigang
    Zhou, Fan
    [J]. ONCOTARGET, 2017, 8 (37) : 62435 - 62444
12345